CORONA REMEDIES
Back to Income Statement
|
CORONA REMEDIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Profit After Tax | ₹149 Cr | ₹905 Cr | ₹85 Cr | ₹85 Cr |
What is the latest Profit After Tax of CORONA REMEDIES ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹149 Cr |
| Mar2025 | ₹905 Cr |
| Mar2024 | ₹85 Cr |
| Mar2023 | ₹85 Cr |
How is Profit After Tax of CORONA REMEDIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹149 Cr | -83.49 | |
| Mar2025 | ₹905 Cr | 965.63 | |
| Mar2024 | ₹85 Cr | 0.00 | |
| Mar2023 | ₹85 Cr | - | |
Compare Profit After Tax of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹13,289.3 Cr | 1% | 3.7% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 1% |
3.7% |
|
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses